에 대한 최신 뉴스 Telos (NASDAQ:TLS) 주식

Telos

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Entertainment

Tech

General

CRWD

최근 조사에 따르면 사이버 보안 위협은 사업주들의 가장 큰 걱정거리로 나타났다. 트래블러스 컴퍼니(Travelers Companies)의 2024 트래블러스 리스크 지수(Travelers Risk Index)에 따르면, 응답자들의 62%가 사이버 리스크에 대해 어느 정도 또는 많은 걱정을 하고 있다고 응답했다.

사이버 보안 공격으로 인한 &#39;치명적 피해&#39;를 62%의 사업주들이 우려: Z스케일러 등의 주식 반응

Telos Corp

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences Ltd

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences Inc

TALISMAN MINING LTD ORD by Talisman Mining Ltd.

Talisman Mining Ltd

Telia Company AB

TELIA COMPANY AB UNSP/ADR by Telia Company AB

TRANSPORTATION & LOGISTIC by Transportation and Logistics Systems, Inc.

Transportation And Logistics Systems Inc

<p>Barclays  analyst Matt Miksic   maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Overweight and raises the price target from $20 to $21.</p>


News

Price Target

Analyst Ratings

ATEC

Barclays Maintains Overweight on Alphatec Holdings, Raises Price Target to $21

<p>Roth MKM  analyst Rohit Kulkarni   downgrades Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) from Buy to Neutral and raises the price target from $116 to $195.</p>


Downgrades

RDDT

Roth MKM Downgrades Reddit to Neutral, Raises Price Target to $195

WIIM

VINC

Vincerx Pharma shares are trading lower after the company announced it may offer and sell $30 million worth of common stock.

<p><a href="https://www.globenewswire.com/Tracker?data=QXq3KhPK_8AZgZP0kL1zm4OuPOBpEPdgK_fp2s7wK5bnwXPy3dRd5xP7xTL19DpM477m4sv30hFbPEa6vL3ajvbyFFCBQDbji-UXrcFNXR8="><strong>KULR Technology Group, Inc.</strong></a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) (the "Company" or "KULR"), a global leader in carbon-based thermal management and battery safety solutions, has announced an innovative collaboration with the prestigious Scripps Research Institute's Baran Lab. Together, the teams have developed a groundbreaking pyrolytic carbon (PC) electrode material, poised to transform synthetic organic electrochemistry.</p>
<p>The jointly developed electrode is a low-cost, robust, and versatile alternative to traditional amorphous carbon materials such as reticulated vitreous carbon (RVC) and glassy carbon (GC). With unparalleled mechanical strength and reactivity comparable to RVC and GC, this novel PC material overcomes the limitations of cost and scalability that have historically constrained large-scale synthetic organic applications.</p>
<p><strong>Key Advancements:</strong></p>
<ul>
<li>Affordable and Scalable: The pyrolytic carbon electrodes are produced using a proprietary chemical vapor deposition (CVD) process, significantly reducing manufacturing costs and making large-scale synthesis feasible.</li>
<li>Versatile Applications: The material performs exceptionally well across a range of electrochemical reactions, including rapid alternating polarity (rAP) Kolbe couplings, which are essential for high-value chemical production.</li>
<li>Durability and Recyclability: Unlike fragile RVC electrodes, PC electrodes are mechanically robust, enabling simple cleaning and reusability without degradation.</li>
</ul>


KULR

KULR Technology Group And Scripps Research Institute's Baran Lab Develop Cost-Effective Pyrolytic Carbon Electrode For Synthetic Organic Electrochemistry; Enhances Scalability, Versatility In Reactions, And Durability With Proprietary Chemical Vapor Deposition Process

<p>Barclays  analyst Kannan Venkateshwar   downgrades Rogers Communications (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RCI#TSX">RCI</a>) from Overweight to Equal-Weight and lowers the price target from C$63 to C$39.</p>


TSX:RCI

TSX:RCI/B

Barclays Downgrades Rogers Communications to Equal-Weight, Lowers Price Target to C$39

Xilio Therapeutics shares are trading lower after the company reported initial data from its ongoing Phase 2 clinical trial evaluating vilastobart in combination with atezolizumab.

Goldman Sachs CEO Solomon Says I Don't Think Bitcoin Is A Threat To The U.S. Dollar

Trading Ideas

RZLV

Rezolve AI Shares Trading Higher; Co Issues Press Release Celebrating Stargate AI Initiative

HUSA

Houston American Energy shares are trading lower after the company announced a $4.42 million registered direct offering.

<p class="wp-embed-aspect-16-9 wp-has-aspect-ratio"><strong>GE Aerospace</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) will release its fourth-quarter financial results before the <a href="https://www.benzinga.com/quote/GE/earnings">opening bell on Thursday, Jan. 23</a>.</p>
<p>Analysts expect the Ohio-based company to report quarterly earnings at $1.04 per share, up from $1.03 per share in the year-ago period. GE Aerospace projects quarterly revenue of $9.47 billion, compared to $19.42 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.</p>
<p>On Jan. 2, Deutsche Bank analyst <strong>Scott Deuschle</strong> maintained GE Aero with a Buy rating and lowered the price target from $235 to $228.</p>
<p>With the recent buzz around GE Aerospace, some investors may be eyeing potential gains from the company's dividends. As of now, GE Aerospace offers an annual dividend yield of 0.60%, which is a quarterly dividend amount of 28 cents per share ($1.12 a year).</p>
<p>To figure out how to earn $500 monthly from GE Aerospace, we start with the yearly target of $6,000 ($500 x 12 months).</p>
<p>Next, we take this amount and divide it by GE Aerospace's $1.12 dividend: $6,000 / $1.12 = 3,000 shares.</p>
<p><strong>So, an investor would need to own approximately $1,004,438 worth of GE Aerospace, or 5,357 shares to generate a monthly dividend income of $500.</strong></p>
<p><strong>Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.12 = 1,071 shares, or $200,813 to generate a monthly dividend income of $100.</strong></p>
<p>Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.</p>
<p>The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.</p>
<p>For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).</p>
<p>Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).</p>
<p>Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.</p>
<p><strong>GE Price Action</strong>: Shares of GE Aerospace gained by 2.5% to close at $187.50 on Tuesday.</p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/01/43096091/jim-cramer-this-tech-stock-is-a-buy-louisiana-pacific-has-been-a-great-stock">Jim Cramer: This Tech Stock Is A Buy, Louisiana-Pacific Has Been A &#8216;Great Stock&#8217;</a></strong></li>
</ul>


Long Ideas

Markets

How To Earn $500 A Month From GE Aerospace Stock Ahead Of Q4 Earnings

USEG

U.S. Energy Corp shares are trading higher. The company announced a public offering of 4,236,000 shares.

<p>Barclays  analyst Kannan Venkateshwar   downgrades BCE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BCE#TSX">BCE</a>) from Equal-Weight to Underweight and lowers the price target from C$41 to C$30.</p>


TSX:BCE

Barclays Downgrades BCE to Underweight, Lowers Price Target to C$30

LSTA

Lisata Therapeutics shares are trading lower after the company announced preliminary cohort data from its Phase 2 Ascend trial.

HPAI

Helport AI Partners With LendSure To Boost Loan Officer Productivity, Reduce Overhead Costs, And Lower Mortgage Expenses For Borrowers; Aims For Industry-Wide Transformation Through AI Integration

HEPA

Hepion Pharmaceuticals shares are trading lower after the company announced a $9 million public offering.

BLBX

Blackboxstocks shares are trading higher after the company announced a $250K securities purchase agreement and is anticipating a potential merger.

Offerings

U.S. Energy Corp. Prices 4,236,000 Share Offering At $2.65/Share

Goldman Sachs CEO Solomon Says Rebalancing Of Certain Trade Agreements Over Time Can Be Constructive For U.S. Growth; I Think It's Hard To Dispute The Fact That Equity Multiples Are High

<p><i>Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFS</i></p>
<p><i>The early-onset broad-spectrum antiviral effect of Ampligen has been observed to stimulate strong innate immune response, offering potential therapeutic benefits for people with ME/CFS or Post-COVID chronic fatigue</i></p>
<p>OCALA, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Lp7r-Zko8_STxa2-SCTwWJh1YHEsWboXq5jsxeXHg-SqFEWiqVGMujh5tpqwQxZY5yu2XZuEKP-kqNipNfkoTz27dgqboQ8x6ThGGR7FHqU="><strong>AIM ImmunoTech Inc.</strong></a><strong> (NYSE:</strong><a href="https://www.benzinga.com/stock/AIM#NYSE"><strong>AIM</strong></a><strong>)&nbsp;</strong>("AIM" or the "Company") today offered commentary on a new article in the <i>Journal of General Internal Medicine</i> linking COVID-19 to increased risk of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ("ME/CFS").</p>
<p>The article, titled "<a href="https://www.globenewswire.com/Tracker?data=Fpq1FisR8Jo1G0UQe1w_Xfyq974COCvW4D_zDbhx6_5A0ny4E4Th5BAnjftaot2-CBsrvkrvPy4vLK9ZH3_XPf6BEtDKxILgAsWUrhbxQtb9G1eL_d0RHXTAtQyiV1dDgtvGWyL_CXYP8dEKM0sl_e5o6kWll7Ml4HPjKmEAZbaCJFKGMw0km6H3jqqnBplMJoqzXHwWq6c0FZBZ48Kk9SNpfqFRHl4ud2cVHkg-JSiJXXFaA4j39hkqvOp3hWvEPVi255ewcc5zYELBzc3yQw==">Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study</a>," found that among study participants infected with SARS-CoV-2, the incidence of ME/CFS was 15 times higher than pre-pandemic rates. The article's lead author, Suzanne D. Vernon, PhD, emphasized the following highlights in an <a href="https://www.globenewswire.com/Tracker?data=IFH4V9qJpmVon0e6WwLx9F-9dJ-PXSwcqmf6AWGKFGpioE4g2C0XT-vTSog6ur1kSKv3Tqel3TlMk2tZv_ZxO8FrpaAyqaJe6oAT9qQmwriMCO59gtO7iuWk983XNcr_9yKUh6iDzSoInm9YYBi9MQ==">accompanying analysis</a> posted to the Bateman Horne center website:</p>
<ul>
<li>Of the 4,515 participants who enrolled within 30 days of contracting COVID-19, 73 developed ME/CFS at least six months post-infection.</li>
<li>In total, 531 participants met ME/CFS criteria, translating to a prevalence of 4.5% among those infected—nearly eight times higher than uninfected participants.</li>
<li>This prevalence is five times higher than pre-pandemic estimates and underscores the severe and lasting impact of COVID-19 on public health.
<ul>
<li>90% of these post-COVID-19 ME/CFS cases clustered with the most symptomatic and severe cases of Long COVID, highlighting the overlap between these two conditions.</li>
</ul>
</li>
</ul>


Biotech

AIM ImmunoTech Announces Commentary On Study Linking COVID-19 To Increased ME/CFS Risk; Incidence 15 Times Higher Than Pre-Pandemic Rates; Ampligen Shows Strong Antiviral Effect Beneficial For ME/CFS And Post-COVID Fatigue; 531 Of 4,515 Participants Affected

<p><strong>Comerica Inc </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) shares are trading lower in premarket Wednesday after the <a target="_blank" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000028412/000002841225000005/cma-20250122.htm" rel="noreferrer noopener">fourth-quarter FY24 earnings result</a>.</p>
<p>The financial services company reported a fourth-quarter revenue increase of 5.5% to $825 million, missing the analyst consensus estimate of $837.98 million.</p>
<p>Net interest income increased $41 million to $575 million quarter-on-quarter, reflecting a strategic growth in core interest-bearing deposits and relationship-focused pricing.</p>
<p>Adjusted EPS of $1.20 also <a href="https://www.benzinga.com/earnings">missed the consensus estimate of $1.28.</a></p>
<p>Average loans in the fourth quarter amounted to $50.62 billion and the return on average assets stood at 0.85%. Efficiency ratio for the quarter was 69.51.</p>
<p>Nonperforming assets increased $58 million to $308 million, or 0.61% of total loans and foreclosed property, compared to 0.50% in the third quarter of 2024.</p>
<p>The company held $850 in cash and equivalents as of December 31, 2024.</p>
<p><strong>Curtis C. Farmer</strong>, Comerica Chairman and Chief Executive Officer, stated, &#8220;As expected, loans were pressured by paydowns in Commercial Real Estate, but we saw promising signals across other businesses that support our outlook for growth in 2025. Although some uncertainty remains, we believe customer sentiment is generally more optimistic about the future of the economy and plans for increased investment in their businesses.&#8221;</p>
<p><strong>Outlook</strong>: Comerica <a target="_blank" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000028412/000002841225000005/cma-20250122.htm" rel="noreferrer noopener">sees </a>FY25 net interest income growth of 6% &#8211; 7%, including the impact of BSBY cessation.</p>
<p>For the first quarter, the company expects net interest income to decline 1% &#8211; 2% sequentially, including the impact of BSBY cessation.</p>
<p>The company targets share repurchases at approximately <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$50 million in the first quarter of 2025</a>.</p>
<p><strong>Price Action</strong>: CMA shares traded lower by 1.78% at $65.20 in premarket at the last check Wednesday.</p>
<p><em>Image: Shutterstock/ fizkes.</em></p>


Equities

Guidance

Movers

Comerica Q4 Earnings: Revenue And EPS Fall Short Amid Loan Pressures, Eyes 2025 Growth

Telos beats top-line and bottom-line estimates; initiates Q4FY24 outlook

Reports Q3 revenue $23.783M, consensus $22.99M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...

Telos reports Q3 EPS (10c), consensus (14c)

Telos Corporation (TLS) Q3 2024 Earnings Call Transcript

Analyst Keith Bachman of BMO Capital maintained a Hold rating on Telos (TLS – Research Report), with a price target of $4.50. Keith Bachman has giv...

Telos Receives Hold Rating Amid Mixed Prospects and Large Contract Challenges

BMO Capital raised the firm's price target on Telos (TLS) to $4.50 from $3 and keeps a Market Perform rating on the shares. The company reported a ...

Telos price target raised to $4.50 from $3 at BMO Capital

Matt Dezort, an analyst from Needham, has initiated a new Hold rating on Telos (TLS). Matt Dezort has given his Hold rating due to a combination of...

Balanced Outlook: Telos's Hold Rating Amid Mixed Financial Signals and Strategic Restructuring

Telos (TLS) Corporation continues to expand locations to enroll consumers in the TSA PreCheck program by opening 15 new locations in Arizona, Calif...

Telos expands enrollment, renewal options by opening fifteen locations

Northland Securities analyst Nehal Chokshi reiterated a Buy rating on Telos (TLS – Research Report) today and set a price target of $8.00. The comp...

Northland Securities Sticks to Their Buy Rating for Telos (TLS)

Telos (TLS) continues to expand locations to enroll consumers in the TSA PreCheck program by opening 15 new locations in Arizona, Colorado, Florida...

Telos (TLS) Corporation announced that it has successfully achieved State Risk and Authorization Management Program, StateRAMP, High authorization,...

Telos achieves StateRAMP high authorization

Press Releases

Telos Corporation, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations

Office Depot and Telos Corporation Surpass 160 TSA PreCheck® Enrollment Locations Nationwide

Telos Corporation to Announce Third Quarter 2024 Financial Results on November 12, 2024

Telos Corporation to Participate in Upcoming Investor Conferences

Earnings

Telos Corporation Announces Third Quarter 2024 Earnings

Telos Corporation Achieves StateRAMP High Authorization

Adeia

Arteris

Airship AI Holdings, Inc - Class A Common Stock

Airship AI Holdings

Alarum Technologies Ltd. - American Depositary Shares

Alarum Technologies

Appian Corporation - Class A Common Stock

Appian

A10 Networks

AuthID

BIO-key International, Inc. - Common Stock

BIO-key Intl

Datasea

Duos Technologies Group, Inc. - Common Stock

Duos Technologies Group

T Stamp

Intellinetics

Intrusion

Iveda Solutions

N-able

OneSpan

Progress Software Corporation - Common Stock

Progress Software

Rapid7

SecureWorks

Silvaco Group

SolarWinds

Xperi

X3 Holdings

Zuora

BMO Capital

B. Riley Securities

DA Davidson

Wedbush

Northland Capital Markets

<p>최근 조사에 따르면 <a href="https://www.benzinga.com/news/24/09/40912191/harris-walz-campaign-targeted-by-russian-hackers-microsoft-threat-analysis-center-notices-shift-in-t" target="_blank" rel="noopener" data-google-interstitial="false">사이버 보안 위협</a>은 사업주들의 가장 큰 걱정거리로 나타났다. 트래블러스 컴퍼니(Travelers Companies)의 2024 트래블러스 리스크 지수(Travelers Risk Index)에 따르면, 응답자들의 62%가 사이버 리스크에 대해 어느 정도 또는 많은 걱정을 하고 있다고 응답했다.</p>
<p>트래블러스의 기업 사이버 책임자인 <strong>팀 프란시스</strong>(Tim Francis)는 &#8220;이번 조사 결과는 사이버 공격이 회사에 미칠 수 있는 사이버 위협과 운영 및 재정적 측면 모두에서 치명적인 피해에 대한 비즈니스 커뮤니티의 인식이 더 높아졌다는 것을 말해준다&#8221;고 말했다. &#8220;문제는 더 많은 기업들이 취약점을 완화하기 위한 도구로 사이버 보험을 확보하고 있지만, 많은 기업들이 위험을 알면서도 여전히 그렇게 하지 않는다는 것이다.&#8221;</p>
<p>이 조사에 따르면 의료비 인플레이션은 자영업자들의 두 번째로 큰 관심사로, 59%가 가장 걱정한다고 답했다. 그 뒤를 이어 직원 복리후생 비용과 경제적 불확실성이 59% 증가하고 인재 유지가 54%로 나타났다.</p>
<p>1,202명의 설문 조사 참가자 중 거의 4분의 1(24%)이 자신의 회사에서 사이버 사고를 경험했다고 답했으며, 절반 이상이 작년에 발생했다.</p>
<p>올해 조사는 자신의 회사가 데이터 유출이나 사이버 사건을 겪었다고 응답한 응답자의 비율이 전년도보다 증가한 9년 만에 8번째였다.</p>
<p class="block core-block">설문 조사에 참여한 사람들 중 3분의 2가 사이버 보험에 가입했다고 답했다. 이는 작년 응답자의 60%, 2018년 조사 응답자의 39%보다 증가한 수치이다.</p>
<p>설문 조사에 따르면 모든 규모의 기업에서 전년 대비 증가한 것으로 나타났다. 중소기업은 34%에서 41%로 증가했고, 중간 규모 기업은 74%에서 77%로 증가했으며, 대기업은 72%에서 78%로 증가했다.</p>
<p>보안 침해와 누군가가 금융 계좌나 통제 시스템에 무단으로 접근하는 것은 기업주가 57%로 가장 걱정하는 사이버 사고 유형으로 꼽혔다. 랜섬웨어는 응답자의 54%를 가장 큰 우려로 꼽았다.</p>
<p>또한, 안전하지 않은 컴퓨팅 습관으로 인한 직원의 위험과 컴퓨터 결함이 각각 53%의 응답자를 걱정하게 만들었다.</p>
<p><strong>주가 움직임:</strong> 사이버 보안 관련 회사들의 주가가 화요일에 상승과 하락을 보였다.</p>
<ul class="block core-block">
<li><strong>텔로스 코퍼레이션</strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>)은 3.09% 하락하여 $3.45에 마감되었다.
<div class="ticker-wrapper">
<div class="sc-ksJPJK fhzazX ticker-box-wrapper">
<div>
<div class="relative w-fit">
<div class="inline-flex relative truncate w-full"></div>
</div>
</div>
</div>
</div>
</li>
<li><strong>Z스케일러</strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>)는 0.37% 상승하여 $174.15에 마감되었다.
<div class="ticker-wrapper">
<div class="sc-ksJPJK fhzazX ticker-box-wrapper">
<div>
<div class="relative w-fit">
<div class="inline-flex relative truncate w-full"></div>
</div>
</div>
</div>
</div>
</li>
<li><strong>센티넬원</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>)은 0.16% 하락하여 $24.25에 마감되었다.
<div class="ticker-wrapper">
<div class="sc-ksJPJK fjwbkc ticker-box-wrapper">
<div>
<div class="relative w-fit"></div>
</div>
</div>
</div>
</li>
<li><strong>크라우드스트라이크 홀딩스</strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>)는 1.57% 하락하여 $288.54에 마감되었다.
<div class="ticker-wrapper">
<div class="sc-ksJPJK fhzazX ticker-box-wrapper">
<div>
<div class="relative w-fit">
<div class="inline-flex relative truncate w-full"></div>
</div>
</div>
</div>
</div>
</li>
</ul>
<p><em>Photo: Shutterstock</em></p>
<p><strong>다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요</strong><br />
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener"><strong>여기를 클릭</strong></a>하여 14일 무료 체험을 시작하세요.</p>

Comments

Telos

뉴스

에 대한 최신 뉴스 Telos (NASDAQ:TLS) 주식

수요일, 9월 25, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌